Amato Otani
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
-
- HIV Research and Treatment
Papers in
-
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 3
- Antifungal resistance and susceptibility 2
- HIV/AIDS drug development and treatment 2
- Infectious Disease Case Reports and Treatments 1
-
- Animal Virus Infections Studies 3
- Co-authors
- Eisuke Adachi (4 shared papers)Hiroshi Yotsuyanagi (7 shared papers)Makoto Saito (7 shared papers)Koh Okamoto (6 shared papers)Shu Okugawa (6 shared papers)Mahoko Ikeda (4 shared papers)Sohei Harada (6 shared papers)Michiko Koga (4 shared papers)
- Journals
- Hepatology Research (1 paper)iScience (1 paper)AIDS Research and Therapy (1 paper)Emerging infectious diseases (1 paper)Human Vaccines & Immunotherapeutics (1 paper)
- Partner nations
- JapanUnited StatesCroatia
In The Last Decade
Amato Otani
11 papers receiving 76 citations
Peers
Comparison fields: 5 of 37
- Infectious Diseases 41
- Virology 8
- Hepatology 5
- Emergency Medicine 5
- Dermatology 5
Countries citing papers authored by Amato Otani
This map shows the geographic impact of Amato Otani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amato Otani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amato Otani more than expected).
Fields of papers citing papers by Amato Otani
This network shows the impact of papers produced by Amato Otani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amato Otani. The network helps show where Amato Otani may publish in the future.
Co-authors
The 25 scholars most cited alongside Amato Otani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 18 | |
| 2 | 2022 | 13 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 9 | |
| 5 | 2023 | 8 | |
| 6 | 2021 | 6 | |
| 7 | 2024 | 5 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2024 | 0 | |
| 13 | 2025 | 0 | |
| 14 | 2023 | 0 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 |
About Amato Otani
Amato Otani is a scholar working on Infectious Diseases, Animal Science and Zoology, Epidemiology, Virology and Emergency Medicine, having authored 16 papers that have together received 76 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (3 papers), Animal Virus Infections Studies (3 papers), Antifungal resistance and susceptibility (2 papers), HIV/AIDS drug development and treatment (2 papers), HIV-related health complications and treatments (2 papers), Streptococcal Infections and Treatments (1 paper) and Infectious Disease Case Reports and Treatments (1 paper). The work is most often cited by research in Infectious Diseases (41 citations), Virology (8 citations), Hepatology (5 citations), Emergency Medicine (5 citations) and Dermatology (5 citations). Amato Otani has collaborated with scholars based in Japan, United States and Croatia. Frequent co-authors include Eisuke Adachi, Hiroshi Yotsuyanagi, Makoto Saito, Koh Okamoto, Shu Okugawa, Mahoko Ikeda, Sohei Harada, Michiko Koga, Kyoji Moriya and Takayuki Shinohara. Their work appears in journals such as Hepatology Research, iScience, AIDS Research and Therapy, Emerging infectious diseases and Human Vaccines & Immunotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.